Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer. - Wikidata - wikimedia - TriplyDB

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

http://www.wikidata.org/entity/Q34147279

about

Screening for Barrett's Esophagus Preoperative serum pre-albumin as an independent prognostic indicator in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer.Mass spectrometry-based serum and plasma peptidome profiling for prediction of treatment outcome in patients with solid malignancies.Progress in the development of protein biomarkers of oesophageal and gastric cancers.Prealbumin/CRP Based Prognostic Score, a New Tool for Predicting Metastasis in Patients with Inoperable Gastric Cancer.Serum amyloid A expression in the breast cancer tissue is associated with poor prognosis.Expression of serum amyloid A in uterine cervical cancer.Clinical value of hematologic test in predicting tumor response to neoadjuvant chemotherapy with esophageal squamous cell carcinoma Multi-modality therapy for cancer of the esophagus and GE junction.Serum proteomics in biomedical research: a systematic review.Novel diagnostic and prognostic biomarkers in esophageal cancer.Current Status of Proteomics of Esophageal Carcinoma.Proteomics approach to identify biomarkers for upper gastrointestinal cancer.A new score for screening of malnutrition in patients with inoperable gastric adenocarcinoma.The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction.Serum differential protein identification of Xinjiang Kazakh esophageal cancer patients based on the two-dimensional liquid-phase chromatography and LTQ MS.Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone.

P2860

Q28080445-171E6413-E93F-4CA5-8BE1-66D05176050D Q33829648-5A8585B0-318E-4F80-B490-DCCC3A01A46C Q34820809-C0A64DDD-6E9D-4174-ADA6-AAB6CAC3A37D Q35238008-12489D11-6BE2-4EE1-A47D-D05D1E50AD1E Q35845797-2595B9A6-C203-4633-84A3-83191AD08FD8 Q36557940-D54A5AE0-42AA-4005-90C6-BDF244976E94 Q37392583-2590261D-C883-4491-AA03-968221236CF6 Q37534891-576F1F27-3616-4C45-8258-22C9083A2C29 Q37609288-C832F66D-5813-4FE5-8BEE-ED463E65E3A3 Q38010632-029B2F9C-C761-42CE-9863-0F364465766E Q38101008-B2F49954-4E34-4E55-B8C7-133C9C567509 Q38149245-C0104098-7A8C-4082-883A-4A7B4C5C5685 Q38966421-1AD04BE4-59B2-4ECC-9904-9D666ABFF67C Q38975703-A6D11748-89B0-4B8B-AF08-E044B3350592 Q40277596-5CE3961E-F996-413D-80C9-7DEFA5E0D51A Q42031892-778182FD-D3C6-4B92-9941-6840C8001522 Q44037318-C9DCACEF-8174-4133-A840-39FC904F6E6A Q47449416-DC63E88B-0179-4B73-B2F2-DEC9D2209471

P2860

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

http://www.wikidata.org/entity/Q34147279

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

@ast

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

@en

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

@nl

type

label

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

@ast

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

@en

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

@nl

prefLabel

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

@ast

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

@en

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

@nl

P1433

Q34147279-7B41DEC1-BADC-4FB8-B2C3-D7BB1592D6E9

P1476

Q34147279-88D2F7DD-5B96-4262-9104-E7815FAC8D14

P2093

Q34147279-45C39685-E0FA-4EBD-8F1F-47D00E46B93C

Q34147279-659B0BA5-FDBE-469A-93B3-F01363580961

Q34147279-8C87016A-5D49-4A01-B8A5-33CE9CE7984E

Q34147279-A3262E42-29BA-46C3-BE7C-D53ECA9D0BBD

Q34147279-C2260527-441B-48B7-A218-F54197B45F41

Q34147279-CE724982-DBEB-48E3-AE2D-86E0C499FF0E

Q34147279-E6EA7BED-F7FA-4E1F-9FCB-2AB633FF9131

P2860

Q34147279-069B1E68-0E57-4E6E-ABC3-3100CB561877

Q34147279-0C028EC8-D8C2-4AB9-812E-D568D814F3DE

Q34147279-20479289-2CE0-4126-AA3C-E99D15519D02

Q34147279-228091BF-CCF5-4A32-8964-2438012285E1

Q34147279-2BC45644-0506-40EB-8AFA-8E5D99BA377C

Q34147279-2EDBD446-8218-4B02-B932-94B520BD0BB2

Q34147279-2F846B5A-3924-420C-AE9C-197C5577D7C3

Q34147279-35CCDDC4-52A1-4716-B43F-1AD01A170105

Q34147279-4DCDC629-898B-4B86-9143-BDB84F4BF360

Q34147279-5415F768-6F0D-4D7D-82B9-0BA82CCC8713

P2888

Q34147279-EABB9EC2-4D15-4867-BAFF-97ACBE4D5E69

P304

Q34147279-EFCDA1D9-1380-4AA6-9E10-269368AC8190

P31

Q34147279-90883619-0A7B-4071-94C0-C00B433DC2CB

P356

Q34147279-5F8BA113-D2AA-4579-9F16-FFC242C9B06B

P407

Q34147279-B3C5ACE3-FE6E-4452-9499-FBA968F3E275

P433

Q34147279-0D589399-0F45-4451-837E-CCDA7593D88B

P478

Q34147279-5FBDDB6B-BFFB-463C-87EF-E695475716A6

P577

Q34147279-8292C43A-0EBE-4868-A316-05F6BD9CBACC

P5875

Q34147279-FF30C370-6398-43AA-8884-9E783DBFE874

P6179

Q34147279-0D6F2D83-AF61-4C3D-935D-C8FF99F1BEA4

P698

Q34147279-85BFCBD3-3D59-4B18-924A-EF7B59E45B27

P932

Q34147279-015F5C66-B5B4-423A-9DB3-757BF573C6AD

P356

P1433

British Journal of Cancer

P1476

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

@en

P2093

A Thompson

http://www.w3.org/2001/XMLSchema#string

D Exon

http://www.w3.org/2001/XMLSchema#string

D Lamont

http://www.w3.org/2001/XMLSchema#string

F Paulin

http://www.w3.org/2001/XMLSchema#string

L Baker

http://www.w3.org/2001/XMLSchema#string

P Kelly

http://www.w3.org/2001/XMLSchema#string

S Clearly

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative chemotherapy for resectable thoracic esophageal cancer

Serum amyloid A: an acute-phase protein involved in tumour pathogenesis

A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials

Possible prediction of chemoradiosensitivity of esophageal cancer by serum protein profiling.

SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer

Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy.

Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?

Oesophageal cancer: a view over overviews.

The clinical application of proteomics.

P2888

P304

955-961

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2012.15

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221795407

http://www.w3.org/2001/XMLSchema#string

P6179

1002789109

http://www.w3.org/2001/XMLSchema#string

P698

22294182

http://www.w3.org/2001/XMLSchema#string

P932

3305965

http://www.w3.org/2001/XMLSchema#string